Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

The authors at King’s College London say that using the radiotracer – an injected compound used in PET scans – could help inform doctors that a patients aggressive cancer will not respond to ...

Many patients with cancer also experience scan-related anxiety (scanxiety), a condition in which individuals develop anxiety ...

This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

MLB Hall of Famer Ryne Sandberg has revealed that his prostate cancer has returned and spread. The former Chicago Cubs star, ...

The firm presented early data for a blood-based approach to screen prostate cancer patients for PSMA, which it believes has ...

A recent study found that fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG PET/CT) was better ...

Cancer is considered metastatic when it has spread to distant lymph nodes ... it has been largely replaced by a combination of PET scans and endobronchial guided ultrasound biopsy, which can often be ...

9Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas. Search for other works by this author on: 9Winthrop P. Rockefeller Cancer Institute, ...

Purpose: This study aimed to develop and validate a model for accurately assessing the risk of distant metastases in patients with gastric cancer (GC ... using whole-body 18F-FDG-PET-CT or ...